Literature DB >> 24760868

Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers.

Marie Lise Frandemiche1, Sandrine De Seranno, Travis Rush, Eve Borel, Auréliane Elie, Isabelle Arnal, Fabien Lanté, Alain Buisson.   

Abstract

Tau is a microtubule-associated protein well known for its stabilization of microtubules in axons. Recently, it has emerged that tau participates in synaptic function as part of the molecular pathway leading to amyloid-beta (Aβ)-driven synaptotoxicity in the context of Alzheimer's disease. Here, we report the implication of tau in the profound functional synaptic modification associated with synaptic plasticity. By exposing murine cultured cortical neurons to a pharmacological synaptic activation, we induced translocation of endogenous tau from the dendritic to the postsynaptic compartment. We observed similar tau translocation to the postsynaptic fraction in acute hippocampal slices subjected to long-term potentiation. When we performed live confocal microscopy on cortical neurons transfected with human-tau-GFP, we visualized an activity-dependent accumulation of tau in the postsynaptic density. Coprecipitation using phalloidin revealed that tau interacts with the most predominant cytoskeletal component present, filamentous actin. Finally, when we exposed cortical cultures to 100 nm human synthetic Aβ oligomers (Aβo's) for 15 min, we induced mislocalization of tau into the spines under resting conditions and abrogated subsequent activity-dependent synaptic tau translocation. These changes in synaptic tau dynamics may rely on a difference between physiological and pathological phosphorylation of tau. Together, these results suggest that intense synaptic activity drives tau to the postsynaptic density of excitatory synapses and that Aβo-driven tau translocation to the spine deserves further investigation as a key event toward synaptotoxicity in neurodegenerative diseases.

Entities:  

Keywords:  LTP; amyloid-beta oligomers; excitatory synapses; phosphorylation; synaptic plasticity; tau

Mesh:

Substances:

Year:  2014        PMID: 24760868      PMCID: PMC6608293          DOI: 10.1523/JNEUROSCI.4261-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  99 in total

1.  Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.

Authors:  Sophie Sokolow; Kristen M Henkins; Tina Bilousova; Bianca Gonzalez; Harry V Vinters; Carol A Miller; Lindsey Cornwell; Wayne W Poon; Karen H Gylys
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

2.  Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer's disease.

Authors:  Alicia M Hall; Benjamin T Throesch; Susan C Buckingham; Sean J Markwardt; Yin Peng; Qin Wang; Dax A Hoffman; Erik D Roberson
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

3.  Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain.

Authors:  Atsuko Kubo; Shouyou Ueda; Ayaka Yamane; Satoko Wada-Kakuda; Mai Narita; Makoto Matsuyama; Akane Nomori; Akihiko Takashima; Taisuke Kato; Osamu Onodera; Motohito Goto; Mamoru Ito; Takami Tomiyama; Hiroshi Mori; Shigeo Murayama; Yasuo Ihara; Hiroaki Misonou; Tomohiro Miyasaka
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

4.  Verapamil Inhibits Ser202/Thr205 Phosphorylation of Tau by Blocking TXNIP/ROS/p38 MAPK Pathway.

Authors:  Mariarosa Anna Beatrice Melone; Clemente Dato; Simona Paladino; Cinzia Coppola; Claudia Trebini; Maria Teresa Giordana; Lorena Perrone
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

Review 5.  Tau: It's Not What You Think.

Authors:  Peter W Baas; Liang Qiang
Journal:  Trends Cell Biol       Date:  2019-03-28       Impact factor: 20.808

6.  Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.

Authors:  Benjamin W Henderson; Erik G Gentry; Travis Rush; Juan C Troncoso; Madhav Thambisetty; Thomas J Montine; Jeremy H Herskowitz
Journal:  J Neurochem       Date:  2016-07-01       Impact factor: 5.372

Review 7.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

8.  Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation.

Authors:  Chuanzhou Li; Jürgen Götz
Journal:  EMBO J       Date:  2017-09-01       Impact factor: 11.598

9.  Pathological missorting of endogenous MAPT/Tau in neurons caused by failure of protein degradation systems.

Authors:  Varun Balaji; Senthilvelrajan Kaniyappan; Eckhard Mandelkow; Yipeng Wang; Eva-Maria Mandelkow
Journal:  Autophagy       Date:  2018-09-13       Impact factor: 16.016

10.  Tau Mislocation in Glucocorticoid-Triggered Hippocampal Pathology.

Authors:  Sara Pinheiro; Joana Silva; Cristina Mota; João Vaz-Silva; Ana Veloso; Vítor Pinto; Nuno Sousa; João Cerqueira; Ioannis Sotiropoulos
Journal:  Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.